MTOR and cancer: Dysregulated MTOR signaling has been implicated in the progression of several diseases including chronic obstructive pulmonary disease, pulmonary arterial hypertension, idiopathic pulmonary fibrosis, heart failure, and cancer (33, 34, 35, 36, 37, 38, 39, 40, 41, 42).